Live feed16:15:25·285dINSIDERFilingvia QuantisnowPresident and Head of R&D Nagendran Sukumar exercised 41,150 shares at a strike of $0.70 and sold $646,000 worth of shares (200,000 units at $3.23), decreasing direct ownership by 14% to 1,006,439 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TSHA· Taysha Gene Therapies Inc.Health CareOriginal source